跳至主要内容
临床试验/EUCTR2019-001987-31-DE
EUCTR2019-001987-31-DE进行中(未招募)1 期

COMBined Active Treatment in Type 2 Diabetes with NASH - COMBAT T2 NASH

Deutsche Diabetes Forschungsgesellschaft e.V.0 个研究点目标入组 192 人开始时间: 2020年6月15日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
192

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Diagnosis of T2D and NASH with fibrosis stage F1-F3
  • - Age between 25 and 75 years
  • - HbA1c = 9.5%
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 100
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 92

排除标准

  • - Contraindications on liver biopsy
  • - Evidence of cirrhosis on liver biopsy
  • - Liver disease of other etiology
  • - History of ketoacidosis
  • - Alcohol consumption >30 g/d for males and >20 g/d for females
  • - Past (=5 years) or current history of alcohol or drug abuse and/or
  • psychiatric disease
  • - Medications that may induce steatosis
  • - Planned pregnancy, pregnant or lactating women, positive pregnancy
  • test, and woman of childbearing potential not using two adequate
  • methods of contraception

研究者

发起方
Deutsche Diabetes Forschungsgesellschaft e.V.

相似试验